Clinical Trial Update: Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating SHR-A1811 with Pyrotinib and Bevacizumab for advanced breast cancer with brain metastases. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Pyrotinib (pyrotinib)
• SHR-A1811

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer Metastatic, Breast Cancer Brain Metastases | Phase 1, Phase 2 | Status: RECRUITING